About
Saculysin 50, likely containing Sacubitril/Valsartan, is a combination medication used for the treatment of chronic heart failure with reduced ejection fraction (HFrEF). It belongs to a class of drugs known as angiotensin receptor-neprilysin inhibitors (ARNIs). Sacubitril inhibits neprilysin, an enzyme responsible for the degradation of natriuretic peptides, leading to increased levels of these peptides which promote vasodilation and natriuresis. Valsartan is an angiotensin II receptor blocker (ARB) that inhibits the effects of angiotensin II, reducing vasoconstriction and aldosterone secretion. The synergistic action of these two components helps to reduce cardiac workload, improve cardiac function, and decrease the risk of cardiovascular death and heart failure hospitalization.
This medication represents a significant advancement in heart failure therapy, offering superior benefits compared to ACE inhibitors or ARBs alone in appropriate patients. It is typically initiated after patients have been stabilized on other heart failure therapies and are able to tolerate the medication's effects on blood pressure and renal function. Close monitoring is required during initiation and dose titration to ensure patient safety and optimize therapeutic outcomes.
Uses
- Treatment of chronic heart failure with reduced ejection fraction.
- Reduction of cardiovascular death and heart failure hospitalization.
- Improvement of symptoms and physical limitations in heart failure.
- Management of symptomatic chronic heart failure in adults.
Directions For Use
Take orally twice daily, preferably at the same times each day, as prescribed by your doctor.
Benefits
- Significantly reduces risk of cardiovascular death.
- Decreases heart failure hospitalizations.
- Improves heart function and symptoms.
- Offers a novel mechanism of action for heart failure.
- Better outcomes compared to traditional therapies.
- Enhances quality of life for heart failure patients.
Side Effects
- Hypotension
- Hyperkalemia
- Renal impairment
- Cough
- Dizziness
- Fatigue
- Nausea
- Diarrhea
- Anemia
- Angioedema
- Syncope
- Orthostatic hypotension
Safety Measures
- Alcohol - May exacerbate hypotension; use with caution and avoid excessive intake.
- Pregnancy - Contraindicated, especially in the second and third trimesters, due to severe fetal harm and death.
- Breastfeeding - Not recommended as it may pass into breast milk and harm the infant; consult a physician.
- Liver - Use with caution in moderate hepatic impairment; not recommended in severe hepatic impairment.
- Kidney - Use with caution in renal impairment; monitor kidney function closely and adjust dose as needed.
- Lung - Generally safe for use in patients with lung conditions; no specific contraindications related to pulmonary function.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!